Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
about
MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.Perspectives on the value of biomarkers in acute cardiac care and implications for strategic managementEffects of B-type natriuretic peptide on cardiovascular biomarkers in healthy volunteers.Elevated PAPP-A sets alarm bells ringing in patients with cardiac chest pain.
P2860
Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Mid-regional pro-atrial natriu ...... matic coronary artery disease.
@en
Mid-regional pro-atrial natriu ...... matic coronary artery disease.
@nl
type
label
Mid-regional pro-atrial natriu ...... matic coronary artery disease.
@en
Mid-regional pro-atrial natriu ...... matic coronary artery disease.
@nl
prefLabel
Mid-regional pro-atrial natriu ...... matic coronary artery disease.
@en
Mid-regional pro-atrial natriu ...... matic coronary artery disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Mid-regional pro-atrial natriu ...... matic coronary artery disease.
@en
P2093
Andreas Schuster
Boris Bigalke
Jana Papassotiriou
Meinrad Gawaz
Oliver Hartmann
Thomas Wurster
Tobias Geisler
Wolfram Doehner
P2860
P304
P356
10.1042/CS20120216
P407
P577
2012-11-01T00:00:00Z